文献速递白血病淋巴瘤

无机焦磷酸酶PPA1对急性B淋巴细胞白血病异常幼稚细胞增殖与凋亡的影响

[Effect of inorganic pyrophosphatase PPA1 on proliferation and apoptosis of abnormal naive cells in acute B-lymphocytic leukemia].
PubMed 文献 · Zhonghua Xue Ye Xue Za Zhi · 2026-01-01

该研究探讨无机焦磷酸酶PPA1在急性B淋巴细胞白血病(B-ALL)异常幼稚淋巴细胞增殖与凋亡中的作用。研究发现B-ALL患者异常幼稚淋巴细胞中PPA1转录与表达水平显著高于正常细胞,重组PPA1蛋白促进B-ALL细胞系增殖,而PPA1单抗及shRNA抑制PPA1表达可抑制增殖、促进凋亡并降低线粒体膜电位,机制涉及PI3K/AKT通路及MDM2、P53调控。

要点

  • B-ALL患者异常幼稚淋巴细胞PPA1转录与表达水平分别为正常细胞的3.75~14.89倍和1.25~3.79倍
  • PPA1单抗(1:500)对NALM-6和HAL-01细胞增殖抑制率分别为49.42%和58.35%
  • 抑制PPA1表达可降低PI3K/AKT通路磷酸化水平并调控MDM2、P53及凋亡相关因子

核心结论

  • PPA1与B-ALL异常幼稚淋巴细胞增殖发育关系密切,抑制PPA1表达可抑制肿瘤细胞增殖并促进凋亡,具有作为肿瘤防治新靶标的潜力。

研究设计与样本

  • 生物信息学分析PPA1基因特性,并收集B-ALL患者骨髓标本经CD19和CD10免疫磁珠分选异常幼稚B淋巴细胞,以正常细胞为对照。
  • 体外培养B-ALL细胞系NALM-6和HAL-01,分别加入重组PPA1蛋白或PPA1单抗,采用CCK-8和流式细胞术检测增殖、凋亡、线粒体膜电位及细胞周期。
  • 构建GV492-PPA1过表达质粒转染细胞,并设计shRNA构建GV644-shPPA1重组质粒经慢病毒转染抑制PPA1表达,检测PI3K/AKT通路关键蛋白及凋亡相关因子表达水平。

主要发现

  • B-ALL患者异常幼稚淋巴细胞中PPA1转录与表达水平分别为正常细胞的3.75~14.89倍和1.25~3.79倍。
  • rPPA1促进NALM-6与HAL-01细胞增殖,10 μg/ml处理72 h后增殖率分别提高29.97%和20.96%,20 μg/ml时提高48.40%和58.08%。
  • PPA1单抗(1:2 000、1:1 000、1:500)抑制NALM-6细胞增殖的抑制率分别为19.53%、46.90%和49.42%,HAL-01细胞分别为22.29%、52.41%和58.35%。
  • PPA1单抗(1:2 000、1:1 000)使NALM-6细胞凋亡率由10.01%升至20.17%和29.11%,HAL-01细胞由12.65%升至18.53%和31.80%。
  • 过表达PPA1 48和72 h后NALM-6细胞增殖率提高25.05%和26.14%,HAL-01细胞提高26.14%和29.25%;抑制PPA1表达后NALM-6细胞抑制率为19.77%(48 h)和28.99%(72 h),HAL-01细胞为20.90%(72 h)。

关键数值与推荐

  • PPA1单抗(1:2 000、1:1 000)处理后JC-1单体比例在NALM-6细胞为对照组的4.08和6.49倍,HAL-01细胞为3.99和6.42倍,线粒体膜电位降低,细胞周期阻滞于G(0)/G(1)期。
  • qPCR和Western blot显示抑制PPA1可降低PI3K/AKT通路磷酸化水平,调控MDM2、P53及凋亡相关因子表达。

临床怎么用

  • PPA1在B-ALL异常幼稚淋巴细胞中高表达,可作为潜在肿瘤标志物进行进一步评估。
  • 靶向抑制PPA1可抑制B-ALL细胞增殖并促进凋亡,为B-ALL治疗提供潜在新靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the role of inorganic pyrophosphatase (PPA1) in the proliferation of abnormal naive lymphocytes in B-cell acute lymphoblastic leukemia (B-ALL) and evaluate its potential as a tumor marker. Methods: Bioinformatics analysis predicted the characteristics of the PPA1 gene. Bone marrow specimens were collected from patients with B-ALL, and abnormal immature B lymphocytes were isolated by CD19 and CD10 immunomagnetic beads, with normal cells as controls. PPA1 expression was detected with quantitative polymerase chain reaction (qPCR) and Western blot. B-ALL cell lines NALM-6 and HAL-01 were cultured in vitro, and recombinant PPA1 protein (rPPA1) or PPA1 monoclonal antibody was added to assess changes in cell proliferation, apoptosis, mitochondrial membrane potential, and cell cycle. The GV492-PPA1 overexpression plasmid was constructed and transfected into cells to assess the effect of PPA1 overexpression. shRNA was designed to construct the GV644-shPPA1 recombinant plasmid, and lentiviral transduction was performed to inhibit PPA1 expression. The impact on tumor cells was observed, and the expression levels of key proteins in the PI3K/AKT pathway and apoptosis-related factors were detected. Results: In abnormal immature B lymphocytes from patients with B-ALL, the transcription and expression levels of PPA1 were 3.75 - 14.89 times and 1.25 - 3.79 times those of normal cells, respectively. rPPA1 promoted NALM-6 and HAL-01 cell proliferation, with increased proliferation rates of 29.97% and 20.96% after treatment with 10 μg/ml for 72 h and 48.40% and 58.08% at 20 μg/ml, respectively. PPA1 monoclonal antibody (1:2 000, 1:1 000, 1:500) significantly inhibited proliferation at 19.53%, 46.90%, and 49.42% for NALM-6 cells and 22.29%, 52.41%, and 58.35% for HAL-01 cells, respectively. PPA1 monoclonal antibody (1:2 000, 1:1 000) induced apoptosis, increasing the apoptosis rate of NALM-6 cells from 10.01% to 20.17% and 29.11%, and that of HAL-01 cells from 12.65% to 18.53% and 31.80%. After treatment with the same PPA1 monoclonal antibody dilutions, the proportion of JC-1 monomers significantly increased, reaching 4.08- and 6.49-fold of the control in NALM-6 cells, and 3.99- and 6.42-fold in HAL-01 cells, indicating a decrease in mitochondrial membrane potential, whereas the cell cycle was arrested at the G(0)/G(1) phase. Overexpression of PPA1 for 48 and 72 h increased the proliferation rate of NALM-6 cells by 25.05% and 26.14%, and that of HAL-01 cells by 26.14% and 29.25%, respectively. PPA1 expression inhibition suppressed proliferation, with inhibition rates of 19.77% (48 h) and 28.99% (72 h) for NALM-6 cells, and 20.90% (72 h) for HAL-01 cells. qPCR and Western blot results revealed that PPA1 inhibition reduced the phosphorylation level of the PI3K/AKT pathway and regulated the expression of MDM2, P53, and apoptosis-related factors. Conclusion: PPA1 is closely associated with the proliferation and development of abnormal immature lymphocytes in B-ALL. PPA1 expression inhibition suppresses abnormal cell proliferation and promotes apoptosis, indicating that PPA1 has potential as a new target for tumor prevention and treatment. 目的: 探讨无机焦磷酸酶(inorganic pyrophosphatase,PPA1)对急性B淋巴细胞白血病(B-cell acute lymphoblastic leukemia,B-ALL)异常幼稚淋巴细胞增殖、凋亡的影响,评估PPA1作为肿瘤标志物的潜力。 方法: 生物信息学分析PPA1基因特性。收集患者骨髓标本,经CD19和CD10免疫磁珠分选异常幼稚B淋巴细胞,以正常细胞为对照,采用qPCR及Western blot法检测PPA1表达。体外培养B-ALL细胞系NALM-6和HAL-01细胞,分别加入重组PPA1蛋白(recombinant PPA1,rPPA1)或PPA1单抗,采用CCK-8实验和流式细胞术检测细胞增殖、凋亡、线粒体膜电位及细胞周期变化。构建GV492-PPA1过表达质粒转染细胞,检测PPA1过表达的影响。设计shRNA构建GV644-shPPA1重组质粒,慢病毒转染抑制细胞PPA1表达,观察对肿瘤细胞的影响,并检测PI3K/AKT通路关键蛋白及凋亡相关因子表达水平。 结果: B-ALL患者异常幼稚淋巴细胞中PPA1转录与表达水平分别为正常细胞的3.75~14.89倍和1.25~3.79倍。rPPA1可促进NALM-6与HAL-01细胞增殖,10 μg/ml处理72 h后,增殖率分别提高29.97%和20.96%;20 μg/ml时提高48.40%和58.08%。PPA1单抗(1∶2 000、1:1 000、1:500)显著抑制增殖,NALM-6细胞增殖抑制率分别为19.53%、46.90%和49.42%,HAL-01细胞分别为22.29%、52.41%和58.35%。PPA1单抗(1:2 000、1:1 000)促进细胞凋亡,使NALM-6细胞凋亡率由10.01%分别升至20.17%和29.11%,HAL-01细胞由12.65%升至18.53%和31.80%。经相同稀释度PPA1单抗处理后,JC-1单体比例显著增加,NALM-6细胞为对照组的4.08和6.49倍,HAL-01细胞为3.99和6.42倍,表明线粒体膜电位降低,同时将细胞周期阻滞于G(0)/G(1)期。过表达PPA1并培养48和72 h后,NALM-6细胞增殖率提高25.05%和26.14%,HAL-01细胞提高26.14%和29.25%;抑制PPA1表达则抑制增殖,NALM-6细胞抑制率为19.77%(48 h)和28.99%(72 h),HAL-01细胞为20.90%(72 h)。qPCR和Western blot检测显示,抑制PPA1可降低PI3K/AKT通路磷酸化水平,调控MDM2、P53及凋亡相关因子表达。 结论: PPA1与B-ALL异常幼稚淋巴细胞增殖发育关系密切,抑制PPA1表达可抑制肿瘤细胞增殖,促进凋亡,具有作为肿瘤防治新靶标的潜力。.

来源:Zhonghua Xue Ye Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Hu CX, Zhang XH, Wang XJ, et al. [Effect of inorganic pyrophosphatase PPA1 on proliferation and apoptosis of abnormal naive cells in acute B-lymphocytic leukemia]. Zhonghua Xue Ye Xue Za Zhi. 2026. PMID: 42706173. doi:10.3760/cma.j.cn121090-20251103-00499

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。